Detalhe da pesquisa
1.
Eribulin in the treatment of advanced breast cancer: real-world scenario from 39 Italian centers - ESEMPiO study.
Future Oncol
; 15(1): 33-44, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30411979
2.
Atypical Uterine Smooth Muscle Tumors: A Retrospective Evaluation of Clinical and Pathologic Features.
Oncology
; 94(1): 1-6, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-28869928
3.
Locally Advanced Cervical Cancer: Is a Trimodality Treatment a Safe and Effective Approach?
Oncology
; 95(4): 239-245, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29920481
4.
Prognostic factors in 868 advanced gastric cancer patients treated with second-line chemotherapy in the real world.
Gastric Cancer
; 20(5): 825-833, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28028664
5.
Comparison of the molecular profile of brain metastases from colorectal cancer and corresponding primary tumors.
Future Oncol
; 13(2): 135-144, 2017 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-27578453
6.
Selecting patients for gastrectomy in metastatic esophago-gastric cancer: clinics and pathology are not enough.
Future Oncol
; 13(25): 2265-2275, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28976226
7.
Translational and clinical research highlights from the 38th San Antonio Breast Cancer Symposium.
Future Oncol
; 12(8): 1005-8, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26856441
8.
A Delphi consensus and open debate on the role of first-line bevacizumab for HER2-negative metastatic breast cancer.
Future Oncol
; 12(22): 2589-2602, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27443691
9.
Impact of body mass index on neoadjuvant treatment outcome: a pooled analysis of eight prospective neoadjuvant breast cancer trials.
Breast Cancer Res Treat
; 150(1): 127-39, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25677740
10.
MGMT promoter methylation status in brain metastases from colorectal cancer and corresponding primary tumors.
Future Oncol
; 11(8): 1201-9, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25832877
11.
Perspectives from American Society of Clinical Oncology: translational and clinical research highlights in breast and colorectal cancers.
Future Oncol
; 10(12): 1901-6, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25386808
12.
How reliable are the available safety data on hormonal stimulation for fertility preservation in young women with newly diagnosed early breast cancer?
Breast Cancer Res Treat
; 168(3): 773-774, 2018 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-29335923
13.
HER-2 Expression in Brain Metastases from Colorectal Cancer and Corresponding Primary Tumors: A Case Cohort Series.
Int J Mol Sci
; 14(2): 2370-87, 2013 Jan 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-23348930
14.
Optimizing CDK4/6 inhibitors in advanced HR+/HER2- breast cancer: A personalized approach.
Crit Rev Oncol Hematol
; 180: 103848, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36257536
15.
Looking for predictive markers in breast cancer.
Lancet Oncol
; 16(1): e1, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25638542
16.
Correction: MGMT promoter methylation in triple negative breast cancer of the GeparSixto trial.
PLoS One
; 16(9): e0257142, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34469495
17.
Eribulin plus trastuzumab in pretreated HER2-positive advanced breast cancer patients: safety and efficacy. An Italian experience.
Tumori
; 106(4): 301-305, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31847742
18.
Post-neoadjuvant strategies in breast cancer: From risk assessment to treatment escalation.
Cancer Treat Rev
; 72: 7-14, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30414986
19.
State of the art in neoadjuvant therapy of breast cancer.
EJC Suppl
; 11(2): 284-5, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26217146
20.
The safety of antiangiogenic agents and PARP inhibitors in platinum-sensitive recurrent ovarian cancer.
Expert Opin Drug Saf
; 16(6): 687-696, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28471247